PMID- 11998561
OWN - NLM
STAT- MEDLINE
DCOM- 20020815
LR  - 20201208
IS  - 0043-5341 (Print)
IS  - 0043-5341 (Linking)
VI  - 152
IP  - 5-6
DP  - 2002
TI  - [Helicobacter pylori infection--clinical aspects and indications for treatment].
PG  - 128-34
AB  - Helicobacter pylori (H. p.) causes active chronic antrum gastritis in all 
      infected patients. In a relatively small percentage complications of H. 
      p.-gastritis including duodenal ulcer, gastric ulcer, giant fold gastritis, 
      lymphocytic gastritis, autoimmune gastritis, gastric carcinoma and gastric MALT 
      lymphoma may develop. Strongly recommended indications for eradication therapy 
      include gastroduodenal ulcer disease, giant fold gastritis, lymphocytic 
      gastritis, autoimmune gastritis, gastric MALT lymphoma, atrophic gastritis, 
      corpus-predominant gastritis, post gastric cancer resection and patients who are 
      first degree relatives of gastric cancer patients. Eradication therapy is 
      controversial in patients with gastroesophageal reflux disease, functional 
      dyspepsia and in patients in whom treatment with nonsteroidal antiinflammatory 
      drugs (NSAID) or long-term treatment with proton pump inhibitors (PPI) is 
      planned.
FAU - Gschwantler, M
AU  - Gschwantler M
AD  - 4. Medizinische Abteilung, Krankenanstalt Rudolfstiftung, Juchgasse 25, A-1030 
      Wien. Michael.Gschwantler@kar.magwien.gv.at
FAU - Bischof, M
AU  - Bischof M
FAU - Singer, Elisabeth
AU  - Singer E
FAU - Weiss, W
AU  - Weiss W
LA  - ger
PT  - Comparative Study
PT  - Journal Article
PT  - Review
TT  - Helicobacter pylori-Infektion--Klinische Aspekte und Behandlungsindikationen.
PL  - Austria
TA  - Wien Med Wochenschr
JT  - Wiener medizinische Wochenschrift (1946)
JID - 8708475
RN  - 0 (Anti-Ulcer Agents)
SB  - IM
MH  - Anti-Ulcer Agents/therapeutic use
MH  - Clinical Trials as Topic
MH  - Helicobacter Infections/*diagnosis/drug therapy
MH  - *Helicobacter pylori
MH  - Humans
MH  - Recurrence
MH  - Stomach Diseases/*diagnosis/drug therapy
RF  - 82
EDAT- 2002/05/10 10:00
MHDA- 2002/08/16 10:01
CRDT- 2002/05/10 10:00
PHST- 2002/05/10 10:00 [pubmed]
PHST- 2002/08/16 10:01 [medline]
PHST- 2002/05/10 10:00 [entrez]
AID - 10.1046/j.1563-258x.2002.02011.x [doi]
PST - ppublish
SO  - Wien Med Wochenschr. 2002;152(5-6):128-34. doi: 10.1046/j.1563-258x.2002.02011.x.